Home > Financial Ratios > LINCOLN PHARMACEUTICALS

LINCOLN PHARMACEUTICALS
EV/Net Sales

    Back to All Ratios
LINCOLN PHARMACEUTICALS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
AD     Remove this Ad

LINCOLN PHARMACEUTICALS Last 5 Year EV/Net Sales History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/Net Sales(x) 1.742.001.271.281.03

What is the latest EV/Net Sales ratio of LINCOLN PHARMACEUTICALS ?

The latest EV/Net Sales ratio of LINCOLN PHARMACEUTICALS is 1.74 based on Mar2025 Consolidated results.
Year EV/Net Sales
Mar20251.74
Mar20242.00
Mar20231.27
Mar20221.28
Mar20211.03

How is EV/Net Sales of LINCOLN PHARMACEUTICALS Trending?

Years EV/Net Sales % Change
Mar2025 1.74
-13.00
Mar2024 2
57.48
Mar2023 1.27
-0.78
Mar2022 1.28
24.27
Mar2021 1.03 -

Other Financial Ratios of LINCOLN PHARMACEUTICALS


Compare EV/Net Sales ratio of peers of LINCOLN PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
LINCOLN PHARMACEUTICALS ₹1,223.1 Cr -1.4% 36.3% 8.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹423,195.0 Cr 3% 9.5% 3.1% Stock Analytics
DIVIS LABORATORIES ₹169,849.0 Cr 1.7% 3.1% 5.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹149,586.0 Cr 4.7% 11.7% 41.1% Stock Analytics
DR REDDYS LABORATORIES ₹109,054.0 Cr 2.1% 6.7% 11.6% Stock Analytics
CIPLA ₹108,703.0 Cr 1.3% 1.3% -9.4% Stock Analytics


LINCOLN PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
LINCOLN PHARMACEUTICALS

-1.4%

36.3%

8.3%

SENSEX

-1.7%

0.5%

8.3%


You may also like the below Video Courses